|
|
Volumn , Issue , 2013, Pages
|
|
Mechanisms of resistance to RAF inhibition in melanomas harboring a BRAF mutation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AKT1 PROTEIN, HUMAN;
ANTINEOPLASTIC AGENT;
B RAF KINASE;
DABRAFENIB;
IMIDAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
OXIME;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
PROTEIN KINASE INHIBITOR;
SULFONAMIDE;
TUMOR PROTEIN;
VEMURAFENIB;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
DISEASE FREE SURVIVAL;
DRUG EFFECTS;
DRUG RESISTANCE;
ENZYME ACTIVATION;
ENZYMOLOGY;
FEEDBACK SYSTEM;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
MELANOMA;
MUTATION;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
ENZYME ACTIVATION;
FEEDBACK, PHYSIOLOGICAL;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMIDAZOLES;
INDOLES;
MAP KINASE SIGNALING SYSTEM;
MELANOMA;
MUTATION;
NEOPLASM PROTEINS;
OXIMES;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
SULFONAMIDES;
|
|
EID: 84952359984
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e80 Document Type: Review |
|
Times cited : (37)
|
|
References (0)
|